Rigel Pharmaceuticals (RIGL) Gross Margin Growth (1y) (2019 - 2026)
Rigel Pharmaceuticals (RIGL) Gross Margin Growth (1y) (2019 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Gross Margin Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
719,706.53 Bn |
719,706.50 Bn |
- |
- |
| 2 |
Belite Bio |
55,800.00 Bn |
55,800.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
18,182.30 Bn |
18,182.29 Bn |
- |
- |
| 4 |
Legend Biotech |
3,154.00 Bn |
3,153.71 Bn |
242.10 Mn |
526.00 |
| 5 |
Akari Therapeutics |
1,844.30 Bn |
1,844.29 Bn |
- |
- |
| 6 |
Evaxion A |
1,567.96 Bn |
1,567.94 Bn |
- |
- |
| 7 |
Psyence Biomedical |
251.43 Bn |
251.42 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
112.56 Bn |
105.31 Bn |
2.59 Bn |
-5.00 |
| 9 |
Abivax |
94.37 Bn |
94.37 Bn |
- |
- |
| 10 |
Rigel Pharmaceuticals |
553.93 Mn |
407.24 Mn |
54.21 Mn |
44.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
44.00 |
| Dec 31, 2025 |
152.00 |
| Sep 30, 2025 |
767.00 |
| Jun 30, 2025 |
319.00 |
| Mar 31, 2025 |
-141.00 |
| Dec 31, 2024 |
54.00 |
| Sep 30, 2024 |
-1,000.00 |
| Jun 30, 2024 |
-362.00 |
| Mar 31, 2024 |
-311.00 |
| Dec 31, 2023 |
-992.00 |
| Sep 30, 2023 |
-339.00 |
| Jun 30, 2023 |
-52.00 |
| Mar 31, 2023 |
-302.00 |
| Dec 31, 2022 |
172.00 |
| Sep 30, 2022 |
-41.00 |
| Jun 30, 2022 |
-298.00 |
| Mar 31, 2022 |
-33.00 |
| Dec 31, 2021 |
-65.00 |
| Sep 30, 2021 |
6.00 |
| Jun 30, 2021 |
125.00 |
